COST-EFFECTIVENESS OF TOCILIZUMAB MONOTHERAPY VERSUS ADALIMUMAB MONOTHERAPY IN THE TREATMENT OF SEVERE ACTIVE RA

被引：0
|
作者：
Carlson, J. J. [1 ]
Ogale, S. [2 ]
Dejonckheere, F. [3 ]
Sullivan, S. D. [1 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Genentech Inc, San Francisco, CA 94080 USA
[3] F Hoffmann La Roche Ltd, Basel, Switzerland
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.1398
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A447 / A447
页数：1
相关论文
共 50 条
  • [1] Cost-Effectiveness of Tocilizumab Monotherapy Vs. Adalimumab Monotherapy in the Treatment of Severe Active Rheumatoid Arthritis.
    Carlson, Josh J.
    Ogale, Sarika
    Dejonckheere, Fred
    Sullivan, Sean
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S1037 - S1038
  • [2] Tocilizumab monotherapy and adalimumab monotherapy go head-to-head in RA
    Jenny Buckland
    [J]. Nature Reviews Rheumatology, 2013, 9 (5) : 260 - 260
  • [3] TOCILIZUMAB MONOTHERAPY COMPARED WITH ADALIMUMAB MONOTHERAPY IN RA: RESULTS OF A 24-WEEK STUDY
    Kavanaugh, Arthur
    Emery, Paul
    van Vollenhoven, Ronald F.
    Dikranian, SAra H.
    Alten, Rieke
    Klearman, Micki
    Musselman, David
    Agarwal, Sunil
    Green, Jennifer
    Gabay, Cem
    [J]. RHEUMATOLOGY, 2013, 52 : 45 - 45
  • [4] Effectiveness and cost-effectiveness of combination therapy versus monotherapy in malignant melanoma
    Oezdemir, Dilay
    Buessgen, Melanie
    [J]. JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2023, 16 (01)
  • [5] Effectiveness and cost-effectiveness of combination therapy versus monotherapy in malignant melanoma
    Dilay Özdemir
    Melanie Büssgen
    [J]. Journal of Pharmaceutical Policy and Practice, 16 (1)
  • [6] PHARMACOECONOMIC EVALUATION OF TOCILIZUMAB MONOTHERAPY VERSUS ADALIMUMAB MONOTHERAPY IN REDUCING DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Navarro Sarabia, F.
    Blanco, F. J.
    Alvaro-Gracia, J.
    Garcia Meijide, J.
    Poveda, J.
    Ruiz-beato, E.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A444 - A444
  • [7] COST-EFFECTIVENESS ANALYSIS OF AN OPIOID IN COMBINATION WITH GABAPENTIN VERSUS MONOTHERAPY FOR THE TREATMENT OF NEUROPATHIC PAIN
    Galindo, L.
    Guajardo, J.
    Plancarte, R.
    Cerezo, O.
    Najera, E.
    Gonzalez, I
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A543 - A544
  • [8] Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial
    Gabay, Cem
    Emery, Paul
    van Vollenhoven, Ronald
    Dikranian, Ara
    Alten, Rieke
    Pavelka, Karel
    Klearman, Micki
    Musselman, David
    Agarwal, Sunil
    Green, Jennifer
    Kavanaugh, Arthur
    [J]. LANCET, 2013, 381 (9877): : 1541 - 1550
  • [9] Analysis of the cost-effectiveness of monotherapy versus fixed dose combination treatment of asthma in Republic of Moldova
    Corlateanu, Alexandru
    Botnaru, Victor
    Procoava, Ana
    Corlateanu, Olga
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [10] COST-EFFECTIVENESS OF GOLIMUMAB VERSUS INFLIXIMAB AND ADALIMUMAB FOR THE TREATMENT OF MODERATE TO SEVERE ULCERATIVE COLITIS
    Thorlund, K.
    Druyts, E.
    Eapen, S.
    Mills, E.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A38 - A38
12345